Literature DB >> 28069471

An Unexpected Fatal CCHF Case and Management of Exposed Health Care Workers.

Goksel Guven1, Leyla Talan2, Neriman Defne Altintas3, Kemal Osman Memikoglu4, Fugen Yoruk5, Alpay Azap6.   

Abstract

Crimean-Congo hemorrhagic fever (CCHF) is a tick borne viral disease which can also be transmitted by direct contact with blood or tissue specimens of infected animals or humans. We present a fatal case of CCHF, who was diagnosed after death, and describe the post-exposure management plan for the health care workers (HCWs) involved in her care. In total of 52 HCWs were involved in the patient's care and they were stratified into risk groups. Overall, 20 HCWs were grouped in high and intermediate risk groups, including the HCW with needle stick injury. High and intermediate risk groups were offered post exposure prophlaxis (PEP) with ribavirin. Fourteen of 20 HCWs started PEP, however 10 ceased after negative CCHF-PCR results. Negative CCHF-PCR results were reported for all HCWs at the 5th day of exposure. Side effects with PEP developed in 5 of HCWs and were mainly gastrointestinal complaints which reversed after drug discontinuation. All HCWs were followed for 14 days both clinically and with laboratory tests. None of the HCWs developed CCHF. PEP with ribavirin can be considered as a safe option in protection.
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Crimean-Congo Hemorrhagic Fever; health care workers; prophylaxis; ribavirin

Mesh:

Substances:

Year:  2017        PMID: 28069471     DOI: 10.1016/j.ijid.2016.12.026

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  4 in total

1.  A case of Crimean-Congo haemorrhagic fever imported in Greece: Contact tracing and management of exposed healthcare workers.

Authors:  Helena C Maltezou; Anna Papa; Sarantoula Ventouri; Charikleia Tseki; Danai Pervanidou; Androula Pavli; Periklis Panagopoulos; Philothei Markatou; Elpida Gavana; Efstratios Maltezos
Journal:  J Infect Prev       Date:  2019-06-06

Review 2.  Post-exposure prophylactic vaccine candidates for the treatment of human Risk Group 4 pathogen infections.

Authors:  James Logue; Ian Crozier; Peter B Jahrling; Jens H Kuhn
Journal:  Expert Rev Vaccines       Date:  2020-01-30       Impact factor: 5.683

3.  Systematic Review and Meta-analysis of Postexposure Prophylaxis for Crimean-Congo Hemorrhagic Fever Virus among Healthcare Workers.

Authors:  Önder Ergönül; Şiran Keske; Melis Gökçe Çeldir; İlayda Arjen Kara; Natalia Pshenichnaya; Gulzhan Abuova; Lucille Blumberg; Mehmet Gönen
Journal:  Emerg Infect Dis       Date:  2018-09       Impact factor: 6.883

4.  Immune responses in multiple hosts to Nucleocapsid Protein (NP) of Crimean-Congo Hemorrhagic Fever Virus (CCHFV).

Authors:  Elif Karaaslan; Nesibe Selma Çetin; Merve Kalkan-Yazıcı; Sevde Hasanoğlu; Faruk Karakeçili; Aykut Özdarendeli; Ahmet Kalkan; Ali Osman Kılıç; Mehmet Ziya Doymaz
Journal:  PLoS Negl Trop Dis       Date:  2021-12-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.